MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by lalala1on Mar 12, 2008 7:54am

303 Views

Post# 14644638

RE: here is the complete story of the debenture

I was doing the math on this and this and all this debt repayment is awesome news. There might be a lot more shares out there 12,429,162 more to be exact or 17% more from last quarter but with just the Feb 20th NR MIR reduced their annual INTEREST payment from $367,750 to $79,166 (or $91937.5/ quarter to $19,791). Then if you include the other debt repayments ($1,156,000 since Nov) they REDUCED their annual interest expense by $541,150 per year. That sounds nice for future potential profitability. P.S. Please check my math to make sure I'm right.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!